John Frederick Ek, Chief Financial Officer at GenMark Diagnostics, Inc. (GNMK), sold 18,475 shares at $14.24 ($263K) on 2021-01-25, disclosed to the SEC on 2021-01-25.
Open-market sale of $263k GNMK by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNMK | SELL | 2020-11-20 | $23K | — | Filing → |
| GNMK | SELL | 2020-09-24 | $1.1M | — | Filing → |
| GNMK | SELL | 2020-09-18 | $149K | — | Filing → |